MediWound Ltd. (MDWD) Stock Ticker
MDWD right now
Market factors today
Unlock the full MDWD picture
About MediWound Ltd.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
MDWD stock facts
| Ticker symbol | MDWD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $177.8M |
| CEO | Ofer Gonen |
| Employees | 121 |
| Headquarters | Yavne, HM, IL |
| IPO date | 2014-03-20 |
| Website | www.mediwound.com |
What you can see for MDWD on Tickr
Live MDWD price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the MDWD report.
Rankings
FAQ
What is the ticker symbol for MediWound Ltd.?
The ticker symbol for MediWound Ltd. is MDWD, listed on the NASDAQ.
What is MDWD?
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn…